Surgery SF Flashcards
preferred primary tretment for GH-secreting microadenomas and macroadenomas
transphenoidal surgery
only prolactinoma has primary treatment of medical
signs of impending respiratory compromise in burns
hoarse voice
wheezing
stridor
subjective dyspnea (particularly concerning symptom)
type of necrotizing faciitis with a monobicrobial source
type 2
GABHS
MRSA
what to do for BIRADS 3
follow up after 6 months
% of malignancy for BIRADS 4B
11-50%
most robust indicators for burn mortality
AGE
BURN SIZE
INIHALATION INJURY
(REVISED BAUX SCORE)
neck zone with highest morbidity and mortality
zone I
amino acid most beneficial in the surgical critical patient
GLUTAMINE?
(primary nutrition source of small intestines)
-added in total parenteral nutrition
“With parenteral glutamine, the patients most likely to benefit are the critically ill and those at high risk of gut dysfunction. In such patients, a dose of 15–25 g per day may be sufficient.” (D’Souza & Powell-Tuck, 2004)
however
according to Schwartz (2019):
“Recently reported data from 2 large RCT in which critically ill patients received GLUTAMINE supplementation demonstrated INCREASED 6-MONTH MORTALITY in the patients who received glutamine. Therefore, glutamine supplementation in the critically ill patient is not currently recommended.”
best studied immune-nutrients
glutamine
arginine
omega-3 PUFA
Most abundant amino acid in the human body
GLUTAMINE (Schwartz)
-comprising nearly 2/3 of the free intracellular amino acid pool
preferred intubation for burn patients
orotracheal intubation
if with subjective dyspnea, elective ENDOTRACHEAL intubation?
2 large-bore IVs are ideal for burn largern than
40% TBSA
burn and prophylactic antibiotics
patients with acute burn injuries shouuld never receive prophylactic antibiotics
this acid causes liquefactive necrosis
hydrofluoric acid
- causes hypocalcemia
- topical application of calcium gluconate
- IV calciu gluconate for systemic hypocalcemia symptoms
this acid has been known to cause hemolysis and hemoglobinuria
formic acid